These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23545097)

  • 1. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity.
    Füllhase C; Hennenberg M; Giese A; Schmidt M; Strittmatter F; Soler R; Gratzke C; Andersson KE; Stief C
    J Urol; 2013 Oct; 190(4):1430-5. PubMed ID: 23545097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor.
    Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE
    Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats.
    Füllhase C; Russo A; Castiglione F; Benigni F; Campeau L; Montorsi F; Gratzke C; Bettiga A; Stief C; Andersson KE; Hedlund P
    J Urol; 2013 Jun; 189(6):2364-70. PubMed ID: 23219540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute administration of sildenafil to rats with detrusor overactivity induced by chronic deficiency of nitric oxide.
    Reges R; D'Ancona C; Mônica F; Antunes E
    Int Braz J Urol; 2013; 39(2):268-75. PubMed ID: 23683673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta3-adrenoceptors in the rat sacral spinal cord and their functional relevance in micturition under normal conditions and in a model of partial urethral obstruction.
    Füllhase C; Soler R; Westerling-Andersson K; Andersson KE
    Neurourol Urodyn; 2011 Sep; 30(7):1382-7. PubMed ID: 21661032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors.
    Fusco F; di Villa Bianca Rd; Mitidieri E; Cirino G; Sorrentino R; Mirone V
    Eur Urol; 2012 Dec; 62(6):1174-80. PubMed ID: 22841676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor.
    Nishiguchi J; Kwon DD; Kaiho Y; Chancellor MB; Kumon H; Snyder PB; Yoshimura N
    BJU Int; 2007 Mar; 99(3):680-6. PubMed ID: 17155980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sildenafil citrate on bladder outlet obstruction: a mouse model.
    Beamon CR; Mazar C; Salkini MW; Phull HS; Comiter CV
    BJU Int; 2009 Jul; 104(2):252-6. PubMed ID: 19154466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats.
    Behr-Roussel D; Oger S; Caisey S; Sandner P; Bernabé J; Alexandre L; Giuliano F
    Eur Urol; 2011 Feb; 59(2):272-9. PubMed ID: 21036463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
    Brock SC; Tonussi CR
    Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction.
    Füllhase C; Soler R; Gratzke C; Brodsky M; Christ GJ; Andersson KE
    BJU Int; 2010 Jul; 106(2):287-93. PubMed ID: 19888972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and functional role of androgen-dependent PDE5 activity in the bladder.
    Filippi S; Morelli A; Sandner P; Fibbi B; Mancina R; Marini M; Gacci M; Vignozzi L; Vannelli GB; Carini M; Forti G; Maggi M
    Endocrinology; 2007 Mar; 148(3):1019-29. PubMed ID: 17138653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats.
    Füllhase C; Schreiber A; Giese A; Schmidt M; Montorsi F; Gratzke C; La Croce G; Castiglione F; Stief C; Hedlund P
    Neurourol Urodyn; 2016 Apr; 35(4):464-70. PubMed ID: 25788026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the adenosine A1 receptor in the lumbosacral spinal cord improves bladder overactivity in rats with cystitis induced by cyclophosphamide.
    Zhang L; Chen X; Li M; Lv R; Gu B; Chen Z
    Int Urol Nephrol; 2023 Sep; 55(9):2183-2191. PubMed ID: 37330931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of phosphodiesterase type 5 inhibitor mechanism of action.
    Dmochowski RR
    J Urol; 2013 Oct; 190(4):1161-2. PubMed ID: 23871932
    [No Abstract]   [Full Text] [Related]  

  • 16. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction.
    Füllhase C; Soler R; Gratzke C; Brodsky M; Christ GJ; Andersson KE
    J Urol; 2010 Aug; 184(2):783-9. PubMed ID: 20639056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not.
    Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R
    Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of TWIK-related arachidonic acid-activated K+ channel in the spinal cord of detrusor overactivity rats after partial bladder outlet obstruction.
    Zhang J; Cao M; Wu X; Chen Y; Liang W; Liang Y
    BMC Urol; 2015 Oct; 15():100. PubMed ID: 26444419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
    Tinel H; Stelte-Ludwig B; Hütter J; Sandner P
    BJU Int; 2006 Dec; 98(6):1259-63. PubMed ID: 16956354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the phosphodiesterase 5 inhibitor Tadalafil on bladder function in a rat model of partial bladder outlet obstruction.
    Kawai Y; Oka M; Yoshinaga R; Fuchikami C; Oyama T
    Neurourol Urodyn; 2016 Apr; 35(4):444-9. PubMed ID: 25703926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.